(DBXD) Xtrackers - DAX - Ratings and Ratios
Equity, Germany, Large-Cap, ETF, EUR
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 12.8% |
| Value at Risk 5%th | 21.5% |
| Relative Tail Risk | 2.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 11.12 |
| CAGR/Max DD | 1.20 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.655 |
| Beta | 0.187 |
| Beta Downside | 0.248 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.92% |
| Mean DD | 2.25% |
| Median DD | 1.56% |
Description: DBXD Xtrackers - DAX November 05, 2025
The Xtrackers DAX UCITS ETF (ticker DBXD) is a Germany-focused equity fund that seeks to replicate the performance of the Morningstar Germany Total Market Index (TME) net-return, EUR-denominated. It is domiciled in Germany and trades on XETRA, offering investors a low-cost, passively managed exposure to the German blue-chip market.
Key additional metrics (as of Q3 2024) include an expense ratio of 0.09 % p.a., total assets under management of roughly €1.2 billion, and a 30-day tracking error of about 0.15 % points, indicating tight alignment with the underlying index. The DAX is heavily weighted toward industrials, automotive, and financial services, sectors that remain sensitive to Germany’s export-driven growth and the Eurozone’s monetary policy stance. Recent data show the DAX’s dividend yield hovering around 2.8 % and a forward-looking price-to-earnings multiple near 13×, both modestly below historical European averages, suggesting a potential valuation edge.
If you want a more granular, data-driven assessment of DBXD’s risk-adjusted performance and how it fits into broader portfolio construction, consider exploring the analytics available on ValueRay.
What is the price of DBXD shares?
Over the past week, the price has changed by +0.72%, over one month by -0.11%, over three months by +1.81% and over the past year by +17.57%.
Is DBXD a buy, sell or hold?
What are the forecasts/targets for the DBXD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 259.4 | 15.2% |
DBXD Fundamental Data Overview November 26, 2025
Market Cap EUR = 6.35b (6.35b EUR * 1.0 EUR.EUR)
Beta = 0.96
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 6.35b EUR (6.35b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 6.35b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 6.35b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.70% (E(6.35b)/V(6.35b) * Re(6.70%) + (debt-free company))
Discount Rate = 6.70% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)